Elbit Medical Technologies Ltd reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was USD 0.348 million compared to USD 0.084 million a year ago. Net loss was USD 17.79 million compared to USD 5.11 million a year ago.

Basic loss per share from continuing operations was USD 0.2 compared to USD 0.06 a year ago. Diluted loss per share from continuing operations was USD 0.2 compared to USD 0.06 a year ago.